| 1 |
31189930 | LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. | 2019 Jun 12 |
1 |
| 2 |
28837141 | Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT. | 2017 Aug 24 |
1 |
| 3 |
25970160 | Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. | 2015 Sep |
4 |
| 4 |
28031890 | Role of STAT3 pathway in genitourinary tumors. | 2015 Nov |
1 |
| 5 |
24307657 | Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells. | 2014 Feb |
6 |